Contract Manufacturers Are the Quiet Growth Story in Puerto Rico

When people talk about Puerto Rico manufacturing, they name the large pharmaceutical brands. Those operations are genuinely important and they anchor the island's reputation.

But some of the more interesting growth over the last several years has come from a different direction: contract development and manufacturing organizations, contract manufacturers, and specialist service providers that make things for other companies.

This gets less attention because the names are less familiar. It is worth paying attention to anyway, because the contract model fits the island unusually well.

Why the model works here

A contract manufacturer sells capability rather than a product. What it needs is a place where capability is cheap to assemble and credible to customers.

Puerto Rico delivers both halves of that.

The capability side is about inputs. Qualified people who already understand regulated manufacturing. Existing facilities. A supplier base built by decades of multinational presence. Sterilization, calibration, testing and tooling services that exist because somebody else needed them first. A contract manufacturer setting up here is assembling from available parts rather than building from nothing.

The credibility side is about jurisdiction. When a CDMO pitches a US pharmaceutical client, being inside the US regulatory and legal system is not a detail. Same FDA. Same intellectual property protection. Same contract enforcement. For a client deciding whether to trust an outside party with a product, that removes a whole category of concern that an offshore provider has to work hard to address.

Cheap and credible together is rare. That combination is the whole business case.

The customer base is already next door

There is a second dynamic that compounds this.

Contract manufacturers want to be near their customers, and the island already has a dense concentration of pharmaceutical, biologics and medical device operations. A CDMO located here is a short drive from potential clients rather than a flight and a time zone away.

That proximity matters more in regulated work than people outside it realize. Tech transfer goes better when engineers can be in the same room. Problem resolution goes faster. Audits are easier to host. Relationships form.

The clustering that benefits the brand manufacturers benefits their service providers too, and then the service providers deepen the cluster further. That is how an industrial ecosystem actually thickens.

Where the research credit lands for a CDMO

This is where contract organizations often undercount themselves badly, and the reason is a misunderstanding about whose research it is.

Puerto Rico's current framework is Act 60-2019, which replaced the earlier statutes including Act 73-2008 (Legacy). The research and development activity credit under §3030.01 is modeled at two fixed rates: 50 percent on direct R&D investment deployed in Puerto Rico into experimental activities, and 20 percent on indirect R&D investment deployed outside Puerto Rico or into incidental activities.

A CDMO frequently assumes that because the product belongs to a client, the development work does not count as its own research. That assumption is too simple and it costs money.

The development work a contract organization performs on its own account — process development, scale-up investigation, analytical method development, formulation problem-solving, tech transfer where the outcome is genuinely uncertain — is engineering effort it is funding and carrying out. Whether that produces a qualifying claim depends on the facts, including the contractual arrangement, who bears the risk and who holds the rights.

That is exactly the kind of question worth asking properly rather than assuming the answer to. The contract terms matter here in a way they do not for a company developing its own product.

What does not qualify, to be clear

Running a validated process to make a client's product is production. Routine release testing is testing. Filling a purchase order is commerce.

The qualifying work is the development effort where something was not known and had to be resolved through systematic investigation. A CDMO does a great deal of that, because solving other people's manufacturing problems is literally the service.

The documentation wrinkle specific to contract work

Contract organizations have a particular challenge: the technical record often lives inside client-specific project files, structured around the client's product rather than around the CDMO's own development activity.

That makes it harder to see the pattern. A team may have solved twenty genuinely hard technical problems in a year, each recorded in a different client folder, with no view that aggregates them as the organization's own research effort.

Fixing this is organizational rather than technical. Define internal development projects alongside the client work. Capture time against them. Write the short technical summary at close. The client deliverable is unaffected; what changes is that your own development activity becomes visible.

The honest constraints

Margin pressure is real in contract manufacturing, which makes the cost base a genuine advantage but also means there is less room for operational surprises. Power continuity planning is not optional.

Client concentration risk is the structural hazard of the model and has nothing to do with location.

And the incentives position comes from a decree, with conditions attached. Nothing here is a statement about what your decree would contain.

Everything in this article is indicative advisory context and should be confirmed against your own facts, your contracts and current administrative practice.

The read

If you run a contract manufacturing or development organization and you have Puerto Rico operations, the question worth answering this quarter is not whether you do research. It is whether anyone has looked at your development activity as your activity rather than as a series of client projects.

In our experience, the answer surprises people in the right direction more often than not.